Stockscreener 앱 받기
4.09
0.74%
0.03
시간 외 거래:
4.16
0.07
+1.71%
전일 마감가:
$4.06
열려 있는:
$4.06
하루 거래량:
224.85K
Relative Volume:
0.08
시가총액:
$51.70M
수익:
-
순이익/손실:
$-30.54M
주가수익비율:
-2.6387
EPS:
-1.55
순현금흐름:
$-18.30M
1주 성능:
-2.62%
1개월 성능:
-17.71%
6개월 성능:
+623.13%
1년 성능:
+1,024%
1일 변동 폭
$4.02
$4.16
1주일 범위
$4.02
$4.3238
52주 변동 폭
$0.202
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
명칭
Unicycive Therapeutics Inc
전화
650-384-0642
주소
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
UNCY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.09 | 52.99M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-21 | 개시 | Guggenheim | Buy |
| 2024-04-04 | 개시 | Piper Sandler | Overweight |
Unicycive Therapeutics Inc 주식(UNCY)의 최신 뉴스
Is it time to cut losses on Unicycive Therapeutics Inc.Free Intraday Trend Analysis for Fast Gains - Newser
Will breakout in Unicycive Therapeutics Inc. lead to full recoveryStock Price Prediction Using AI Tools - Newser
Is Unicycive Therapeutics Inc. impacted by rising ratesFree Screener for Explosive Stocks - thegnnews.com
Using Python tools to backtest Unicycive Therapeutics Inc. strategiesFree Exit Ready Momentum Stock Watchlist - Newser
Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionAnnual Market Behavior and Sector Summary - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc. - GlobeNewswire Inc.
Does Unicycive Therapeutics Inc. qualify in momentum factor screeningSmart Entry Watchlist with Daily Analysis - Newser
Is a relief rally coming for Unicycive Therapeutics Inc. holdersFree Reliable Chart-Based Trade Entries - Newser
How to integrate Unicycive Therapeutics Inc. into portfolio analysis toolsFree AI Driven Buy Alert Trade Blueprint - Newser
What high frequency data says about Unicycive Therapeutics Inc.Swing Entry Risk Mitigation with Chart Analysis - Newser
Institutional scanner results for Unicycive Therapeutics Inc.Free Stable Entry High Return Opportunities - Newser
Technical signs of recovery in Unicycive Therapeutics Inc.Buy and Exit Strategy Based on Momentum - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc.UNCY - PR Newswire
Real time pattern detection on Unicycive Therapeutics Inc. stockCommunity Picked Stocks with Trade Insights - Newser
Real time social sentiment graph for Unicycive Therapeutics Inc.Long-Term Stock Growth Forecast Insights - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Shareholders to Connect - ACCESS Newswire
Does Unicycive Therapeutics Inc. fit your quant trading modelPortfolio Risk Distribution Analysis Tool - Newser
Momentum divergence signals in Unicycive Therapeutics Inc. chartRSI and MACD Signal Summary with Trends - Newser
What drives Unicycive Therapeutics Inc. stock priceNavigate the market with precision tools - Jammu Links News
Unicycive Therapeutics Inc. Stock Analysis and ForecastBuild wealth faster with expert stock picks - Jammu Links News
What are Unicycive Therapeutics Inc. company’s key revenue driversFind the best stocks for sustainable growth - Jammu Links News
Technical analysis overview for Unicycive Therapeutics Inc. stockPrice Action Summary and Entry Strategy Guide - Newser
What makes Unicycive Therapeutics Inc. stock price move sharplyOutstanding trading profits - Jammu Links News
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Up 1,211.2% in July - Defense World
Is Unicycive Therapeutics Inc. a growth stock or a value stockFree Popular Stock Recommendations - Jammu Links News
Does Unicycive Therapeutics Inc. stock perform well during market downturnsExceptional financial outcomes - Jammu Links News
What are the technical indicators suggesting about Unicycive Therapeutics Inc.Jaw-dropping returns - Jammu Links News
How many analysts rate Unicycive Therapeutics Inc. as a “Buy”High-profit capital plays - Jammu Links News
When is Unicycive Therapeutics Inc. stock expected to show significant growthExceptional gains - Jammu Links News
Unicycive Therapeutics Inc. stock trendline breakdownWeekly Stock Picks with Trend Confidence - Newser
Bronstein, Gewirtz & Grossman, LLC Is Investigating Unicycive Therapeutics, Inc. (UNCY) And Encourages Stockholders to Connect - ACCESS Newswire
Quantitative breakdown of Unicycive Therapeutics Inc. recent moveDaily Investment Ideas with Market Insight - Newser
Unicycive Therapeutics Inc. stock trend forecastDaily Upside Movement Prediction With Data - Newser
Why is Unicycive Therapeutics Inc. stock attracting strong analyst attentionWealth Building Insights With Low Risk - jammulinksnews.com
How does Unicycive Therapeutics Inc. compare to its industry peersPre Market Ideas For Beginners - Jammu Links News
Today's SEC FilingsLatest 10-K, 10-Q, 8-K Forms - Stock Titan
Unicycive Therapeutics, Inc.'s (NASDAQ:UNCY) Path To Profitability - 富途牛牛
Sector ETF performance correlation with Unicycive Therapeutics Inc.Investment Strategy With Predictable Gains Outlined - metal.it
Unicycive Therapeutics (NASDAQ:UNCY) Trading Down 6.2% – Here’s What Happened - Defense World
Evaluating Unicycive Therapeutics Inc. with trendline analysisReal Time Alert System for Market Moves - Newser
Unicycive Therapeutics Inc (UNCY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):